 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Leerink Partners analyst Daina Graybosch has maintained their bullish stance on MRK stock, giving a Buy rating on November 29. Daina Graybosch has...

Buy Rating for Merck & Co. on Strong Prospects for New Pneumococcal Vaccine V116

Merck & Co Inc (MRK) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average DividendRank statistics including a strong...

Merck a Top Socially Responsible Dividend Stock With 3.0% Yield (MRK)

Van Cleef Asset Management Inc lifted its holdings in Merck  Co., Inc. (NYSE:MRK  Free Report) by 1.0% in the 2nd quarter, according to its most recent Form 13F filing with the...

Van Cleef Asset Management Inc Boosts Stake in Merck & Co., Inc. (NYSE:MRK)

(MRK) - Analyzing Merck & Co's Short Interest

Partners Capital Investment Group LLP acquired a new stake in shares of Merck  Co., Inc. (NYSE:MRK  Free Report) during the second quarter, according to its most recent Form 13F filing...

Partners Capital Investment Group LLP Takes Position in Merck & Co., Inc. (NYSE:MRK)

Kayne Anderson Rudnick Investment Management LLC decreased its position in shares of Merck  Co., Inc. (NYSE:MRK  Free Report) by 2.6% in the second quarter, according to the company in...

Merck & Co., Inc. (NYSE:MRK) Position Lessened by Kayne Anderson Rudnick Investment Management LLC

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics...

FDA Grants Priority Review to Mercks Application for KEYTRUDA (pembrolizumab) Plus Padcev (enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer

Merck & Co., Inc. (MRK) Management Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript...

Merck & Co., Inc. (MRK) Management Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN) to help Merck (NYSE: MRK), known as MSD outside...

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-3, a Phase 3 trial evaluating V116, the companys investigational 21-valent pneumococcal...

Mercks V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Watchers	21,868
52-Wk Low	$96.36
52-Wk High	$119.65

Market Cap	$370.99B
Volume (M)	1,554.00
52-Wk High	$119.65
52-Wk Low	$96.36

MRK Merck & Co Inc

About

Feed

News

Sentiment

Earnings

Fundamentals